JESSICA WINDLE: Open Payments
NPI 1033822754 · RADFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 89 payments from 23 companies in 2025. Trend: 2023 $984 · 2024 $1,077 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $203 |
| Novo Nordisk Inc | 9 | $193 |
| Otsuka America Pharmaceutical, Inc. | 7 | $175 |
| AstraZeneca Pharmaceuticals LP | 9 | $166 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Lundbeck LLC | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| ABBVIE INC. | 4 | $72 |
Products named: REXULTI, CAPLYTA, NURTEC ODT, Ozempic, TRELEGY ELLIPTA, AIRSUPRA, SPRAVATO, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
